# BRN Reviews > BRN Reviews ## Posts - [Rethinking obstructive sleep apnoea: integrating precision medicine and technological advances across the lifespan](https://brnreviews.com/en/2026/rethinking-obstructive-sleep-apnoea-integrating-precision-medicine-and-technological-advances-across-the-lifespan/): The full content will be available shortly. Thank you for your patience! - [Co-morbid insomnia and sleep apnea and cardiovascular consequences: is the whole greater than each part?](https://brnreviews.com/en/2026/co-morbid-insomnia-and-sleep-apnea-and-cardiovascular-consequences-is-the-whole-greater-than-each-part/): The full content will be available shortly. Thank you for your patience! - [Obstructive sleep apnea in obesity: traditional and emerging treatment strategies](https://brnreviews.com/en/2026/obstructive-sleep-apnea-in-obesity-traditional-and-emerging-treatment-strategies/): The full content will be available shortly. Thank you for your patience! - [Approach to obstructive sleep apnea in children from a cardiovascular perspective](https://brnreviews.com/en/2026/approach-to-obstructive-sleep-apnea-in-children-from-a-cardiovascular-perspective/): The full content will be available shortly. Thank you for your patience! - [New bio signals in sleep studies scoring](https://brnreviews.com/en/2026/new-bio-signals-in-sleep-studies-scoring/): The full content will be available shortly. Thank you for your patience! - [Artificial intelligence applied to sleep medicine](https://brnreviews.com/en/2026/artificial-intelligence-applied-to-sleep-medicine/): The full content will be available shortly. Thank you for your patience! - [Phage therapy in mycobacteria](https://brnreviews.com/en/2025/phage-therapy-in-mycobacteria/) - [The role of antimicrobial stewardship in the management of tuberculosis](https://brnreviews.com/en/2025/the-role-of-antimicrobial-stewardship-in-the-management-of-tuberculosis/) - [A holistic approach to the treatment of drug-resistant tuberculosis](https://brnreviews.com/en/2025/a-holistic-approach-to-the-treatment-of-drug-resistant-tuberculosis/) - [Tuberculosis without microbiological confirmation](https://brnreviews.com/en/2025/tuberculosis-without-microbiological-confirmation/) - [Tuberculosis screening in vulnerable populations](https://brnreviews.com/en/2025/tuberculosis-screening-in-vulnerable-populations/) - [Update in diagnosis and treatment of idiopathic pulmonary fibrosis](https://brnreviews.com/en/2025/update-in-diagnosis-and-treatment-of-idiopathic-pulmonary-fibrosis/) - [When interstitial lung diseases associates pulmonary hypertension, what to do?](https://brnreviews.com/en/2025/when-interstitial-lung-diseases-associates-pulmonary-hypertension-what-to-do/) - [Current management in hypersensitivity pneumonitis](https://brnreviews.com/en/2025/current-management-in-hypersensitivity-pneumonitis/) - [Genetics of fibrosing interstitial lung diseases](https://brnreviews.com/en/2025/genetics-of-fibrosing-interstitial-lung-diseases/) - [Novelties in the treatment of community-acquired and hospital-acquired pneumonia](https://brnreviews.com/en/2025/novelties-in-the-treatment-of-community-acquired-and-hospital-acquired-pneumonia/) - [Molecular diagnostic techniques in respiratory infections](https://brnreviews.com/en/2025/molecular-diagnostic-techniques-in-respiratory-infections/) - [Aspiration pneumonia: epidemiology, risk factors, etiology, diagnosis, treatment, prophylaxis, and prognosis](https://brnreviews.com/en/2025/aspiration-pneumonia-epidemiology-risk-factors-etiology-diagnosis-treatment-prophylaxis-and-prognosis/) - [Hospital-acquired pneumonia: risk factors and prognosis, microbial etiology, treatment, and prophylaxis](https://brnreviews.com/en/2025/hospital-acquired-pneumonia-risk-factors-and-prognosis-microbial-etiology-treatment-and-prophylaxis/) - [Community-acquired pneumonia: risk factors, prognosis, microbial etiology, treatment, and prophylaxis](https://brnreviews.com/en/2025/community-acquired-pneumonia-risk-factors-prognosis-microbial-etiology-treatment-and-prophylaxis/) - [Acute bronchitis](https://brnreviews.com/en/2025/acute-bronchitis/) - [Long-term non-invasive ventilation in pediatric neuromuscular diseases: challenges and advances](https://brnreviews.com/en/2025/long-term-non-invasive-ventilation-in-pediatric-neuromuscular-diseases-challenges-and-advances/) - [Exercise and chronic pulmonary diseases in pediatrics](https://brnreviews.com/en/2025/exercise-and-chronic-pulmonary-diseases-in-pediatrics/) - [Chronic pulmonary aspiration in children](https://brnreviews.com/en/2025/chronic-pulmonary-aspiration-in-children/) - [Primary ciliary dyskinesia](https://brnreviews.com/en/2025/primary-ciliary-dyskinesia/) - [Bronchiectasis in pediatrics](https://brnreviews.com/en/2025/bronchiectasis-in-pediatrics/) - [Thoracoscopy and talc pleurodesis for malignant pleural effusions](https://brnreviews.com/en/2024/thoracoscopy-and-talc-pleurodesis-for-malignant-pleural-effusions/) - [Tunneled pleural catheter in pleural effusion: To Whom? When? How?](https://brnreviews.com/en/2024/tunneled-pleural-catheter-in-pleural-effusion-to-whom-when-how/) - [Ultrasound and pleural pathology: a great ally](https://brnreviews.com/en/2024/ultrasound-and-pleural-pathology-a-great-ally/) - [Biomarkers of malignancy in pleural effusions](https://brnreviews.com/en/2024/biomarkers-of-malignancy-in-pleural-effusions/) - [Pleural effusion: diagnostic approach](https://brnreviews.com/en/2024/pleural-effusion-diagnostic-approach/) - [Interventional therapies in acute pulmonary embolism](https://brnreviews.com/en/2024/interventional-therapies-in-acute-pulmonary-embolism/) - [Ambulatory management of acute pulmonary embolism](https://brnreviews.com/en/2024/ambulatory-management-of-acute-pulmonary-embolism/) - [Novelties on treatment of hemodynamically stable pulmonary embolism from 2019 to present](https://brnreviews.com/en/2024/novelties-on-treatment-of-hemodynamically-stable-pulmonary-embolism-from-2019-to-present/) - [Current strategies for the diagnosis of pulmonary embolism](https://brnreviews.com/en/2024/current-strategies-for-the-diagnosis-of-pulmonary-embolism/) - [New insights in excessive dynamic airway collapse (EDAC) and tracheobronchomalacia](https://brnreviews.com/en/2024/new-insights-in-excessive-dynamic-airway-collapse-edac-and-tracheobronchomalacia/) - [Quality standards for cryobiopsy](https://brnreviews.com/en/2024/quality-standards-for-cryobiopsy/) - [3D Printed tracheobronchial stents: personalized medicine in silicone](https://brnreviews.com/en/2024/3d-printed-tracheobronchial-stents-personalized-medicine-in-silicone/) - [The role of interventional pulmonology in the diagnosis and management of undiagnosed pleural effusions](https://brnreviews.com/en/2024/the-role-of-interventional-pulmonology-in-the-diagnosis-and-management-of-undiagnosed-pleural-effusions/) - [Optimizing treatment success in lung cancer: the role of functional testing](https://brnreviews.com/en/2024/optimizing-treatment-success-in-lung-cancer-the-role-of-functional-testing/) - [Advances in thoracic surgery: from diagnosing nodules to treating locally advanced lung cancer](https://brnreviews.com/en/2024/advances-in-thoracic-surgery-from-diagnosing-nodules-to-treating-locally-advanced-lung-cancer/) - [The expanding importance of tissue sample analysis for biomarker testing in non-small cell lung cancer management and survival](https://brnreviews.com/en/2024/the-expanding-importance-of-tissue-sample-analysis-for-biomarker-testing-in-non-small-cell-lung-cancer-management-and-survival/) - [Air pollution and lung cancer](https://brnreviews.com/en/2024/air-pollution-and-lung-cancer/) - [Quality requirements to establish a successful lung cancer screening program](https://brnreviews.com/en/2024/quality-requirements-to-establish-a-successful-lung-cancer-screening-program/) - [Objective measurement of cough](https://brnreviews.com/en/2023/objective-measurement-of-cough/) - [A semantic approach to chronic cough](https://brnreviews.com/en/2023/a-semantic-approach-to-chronic-cough/) - [Use of Bacteriophages in Lung Transplantation](https://brnreviews.com/en/2023/use-of-bacteriophages-in-lung-transplantation/) - [Gastroesophageal Reflux in Lung Transplantation](https://brnreviews.com/en/2023/gastroesophageal-reflux-in-lung-transplantation/) - [Cellular Biomarkers of Rejection in Lung Transplant: The Usefulness of Eosinophil and Lymphocyte Counts](https://brnreviews.com/en/2023/cellular-biomarkers-of-rejection-in-lung-transplant-the-usefulness-of-eosinophil-and-lymphocyte-counts/) - [Impact of Chronic Cough on Quality of Life](https://brnreviews.com/en/2023/impact-of-chronic-cough-on-quality-of-life/) - [Obese Asthma Syndrome, Glucocorticoids, and Vitamin D: Mechanisms and Implications](https://brnreviews.com/en/2023/obese-asthma-syndrome-glucocorticoids-and-vitamin-d-mechanisms-and-implications/) - [Asthma in the Elderly: Systematic Approach to Improve the Prognosis](https://brnreviews.com/en/2023/asthma-in-the-elderly-systematic-approach-to-improve-the-prognosis/) - [Role of the TSLP and its Receptor in the Treatment of Asthma](https://brnreviews.com/en/2023/role-of-the-tslp-and-its-receptor-in-the-treatment-of-asthma/) - [Inhaled Treatments for Bronchial Asthma: Molecules and Devices](https://brnreviews.com/en/2023/inhaled-treatments-for-bronchial-asthma-molecules-and-devices/) - [A New Therapeutic Approach Based on a Reinterpretation of Asthma Control](https://brnreviews.com/en/2023/a-new-therapeutic-approach-based-on-a-reinterpretation-of-asthma-control/) - [Macrolides: Indications and Contraindications](https://brnreviews.com/en/2023/macrolides-indications-and-contraindications/) - [Phosphodiesterase Inhibitors: Present and Future](https://brnreviews.com/en/2023/phosphodiesterase-inhibitors-present-and-future/) - [Mucolytics/antioxidants: When Are They Useful?](https://brnreviews.com/en/2023/mucolytics-antioxidants-when-are-they-useful/) - [Triple Therapy for COPD: Historical Perspective and Current Controversies](https://brnreviews.com/en/2023/triple-therapy-for-copd-historical-perspective-and-current-controversies/) - [Long-acting Bronchodilators in COPD Management: One or Two?](https://brnreviews.com/en/2023/long-acting-bronchodilators-in-copd-management-one-or-two/) - [The RICU during the COVID Pandemic](https://brnreviews.com/en/2022/the-ricu-during-the-covid-pandemic/) - [Prolonged Weaning and Respiratory Intensive Care Units. A Narrative Review](https://brnreviews.com/en/2022/prolonged-weaning-and-respiratory-intensive-care-units-a-narrative-review/) - [Selection of Patients for Admission to the Respiratory Intermediate Care Unit](https://brnreviews.com/en/2022/selection-of-patients-for-admission-to-the-respiratory-intermediate-care-unit/) - [Types of Respiratory Intermediate Care Units](https://brnreviews.com/en/2022/types-of-respiratory-intermediate-care-units/) - [New Therapeutic Pathways in Pulmonary Arterial Hypertension](https://brnreviews.com/en/2022/new-therapeutic-pathways-in-pulmonary-arterial-hypertension/) - [Exercise Pulmonary Hypertension](https://brnreviews.com/en/2022/exercise-pulmonary-hypertension/) - [Diagnostic and Therapeutic Challenges for Patients with Pulmonary Hypertension due to Lung Diseases](https://brnreviews.com/en/2022/diagnostic-and-therapeutic-challenges-for-patients-with-pulmonary-hypertension-due-to-lung-diseases/) - [Complexity and Heterogeneity in Bronchiectasis: Towards a Personalized Medicine](https://brnreviews.com/en/2022/complexity-and-heterogeneity-in-bronchiectasis-towards-a-personalized-medicine/) - [Bronchiectasis and Other Chronic Airway Diseases: A Clinical-based Approach](https://brnreviews.com/en/2022/bronchiectasis-and-other-chronic-airway-diseases-a-clinical-based-approach/) - [Bronchiectasis and Quality of Life; Which is the Best Questionnaire?](https://brnreviews.com/en/2022/bronchiectasis-and-quality-of-life-which-is-the-best-questionnaire/) - [The Etiological Screening of Bronchiectasis](https://brnreviews.com/en/2022/the-etiological-screening-of-bronchiectasis/) - [Management of Bronchiectasis in Adults](https://brnreviews.com/en/2022/management-of-bronchiectasis-in-adults/) - [Pulmonary Fibrosis in Sarcoidosis](https://brnreviews.com/en/2021/pulmonary-fibrosis-in-sarcoidosis/) - [Diagnostic and Therapeutic Challenges for Patients with Idiopathic Pulmonary Fibrosis and Lung Cancer](https://brnreviews.com/en/2021/diagnostic-and-therapeutic-challenges-for-patients-with-idiopathic-pulmonary-fibrosis-and-lung-cancer/) - [Non-invasive Biomarkers of Idiopathic Pulmonary Fibrosis and Lung Cancer](https://brnreviews.com/en/2021/non-invasive-biomarkers-of-idiopathic-pulmonary-fibrosis-and-lung-cancer/) - [Mechanotherapeutics for the Treatment of Idiopathic Pulmonary Fibrosis](https://brnreviews.com/en/2021/mechanotherapeutics-for-the-treatment-of-idiopathic-pulmonary-fibrosis/) - [Cellular Mechanisms in the Pathogenesis of Idiopathic Pulmonary Fibrosis](https://brnreviews.com/en/2021/cellular-mechanisms-in-the-pathogenesis-of-idiopathic-pulmonary-fibrosis/) - [In Utero Exposure to Organic Pollutants and Lung Function in the Offspring](https://brnreviews.com/en/2021/in-utero-exposure-to-organic-pollutants-and-lung-function-in-the-offspring/) - [Vegetation, Air Pollution, and Asthma and Allergy: A Narrative Review](https://brnreviews.com/en/2021/vegetation-air-pollution-and-asthma-and-allergy-a-narrative-review/) - [New Occupational Exposures with Respiratory Effects](https://brnreviews.com/en/2021/new-occupational-exposures-with-respiratory-effects/) - [Respiratory Effects of Exposure to Environmental Noise Levels and Noise Annoyance](https://brnreviews.com/en/2021/respiratory-effects-of-exposure-to-environmental-noise-levels-and-noise-annoyance/) - [From systemic effects of COPD to COPD as pulmonary component of multimorbidity](https://brnreviews.com/en/2020/from-systemic-effects-of-copd-to-copd-as-pulmonary-component-of-multimorbidity/) - [Artificial Intelligence in COPD: New Venues to Study a Complex Disease](https://brnreviews.com/en/2020/artificial-intelligence-in-copd-new-venues-to-study-a-complex-disease/) - [Advances in Chronic Obstructive Pulmonary Disease Imaging](https://brnreviews.com/en/2020/advances-in-chronic-obstructive-pulmonary-disease-imaging/) - [Lung Function Trajectories: a New Framework to Understand Adult Chronic Respiratory Diseases](https://brnreviews.com/en/2020/lung-function-trajectories-a-new-framework-to-understand-adult-chronic-respiratory-diseases/) - [Integrating Genetics and Omics to Understand Chronic Obstructive Pulmonary Disease](https://brnreviews.com/en/2020/integrating-genetics-and-omics-to-understand-chronic-obstructive-pulmonary-disease/) - [Relevance of Symptom Variability for Control and Management of COPD](https://brnreviews.com/en/2020/relevance-of-symptom-variability-for-control-and-management-of-copd/) - [Lung Hyperinflation in Chronic Obstructive Pulmonary Disease: Clinical and Therapeutic Relevance](https://brnreviews.com/en/2020/lung-hyperinflation-in-chronic-obstructive-pulmonary-disease-clinical-and-therapeutic-relevance/) - [Non-invasive Ventilation and High Flow Nasal Therapy in Acute Respiratory Failure: 2019 Novelties](https://brnreviews.com/en/2020/non-invasive-ventilation-and-high-flow-nasal-therapy-in-acute-respiratory-failure-2019-novelties/) - [Obesity Hypoventilation Syndrome: New Insights](https://brnreviews.com/en/2020/obesity-hypoventilation-syndrome-new-insights/) - [Sleep Apnoea and Cancer: Is There a Relationship?](https://brnreviews.com/en/2020/sleep-apnoea-and-cancer-is-there-a-relationship/) - [The Case of Sleep Apnoea and Cardiovascular Events](https://brnreviews.com/en/2020/the-case-of-sleep-apnoea-and-cardiovascular-events/) - [The Multiple Inert Gas Elimination Technique 50 years later: Lessons Learned](https://brnreviews.com/en/2019/the-multiple-inert-gas-elimination-technique-50-years-later-lessons-learned/) - [The Case of Procalcitonin for Lower Respiratory Tract Infections](https://brnreviews.com/en/2019/the-case-of-procalcitonin-for-lower-respiratory-tract-infections/) - [Chronic Obstructive Pulmonary Disease Exacerbations: Current Controversies](https://brnreviews.com/en/2019/chronic-obstructive-pulmonary-disease-exacerbations-current-controversies/) - [The Canadian Cohort Obstructive Lung Disease (CanCOLD): New Insights for Primary Care Application](https://brnreviews.com/en/2019/the-canadian-cohort-obstructive-lung-disease-cancold-new-insights-for-primary-care-application/) - [Insights into Chronic Obstructive Pulmonary Disease Epidemiology, Phenotypes and Outcomes from SPIROMICS](https://brnreviews.com/en/2019/insights-into-chronic-obstructive-pulmonary-disease-epidemiology-phenotypes-and-outcomes-from-spiromics/) - [Physical Activity and Underlying Muscle Biology in Chronic Obstructive Pulmonary Disease (COPD)](https://brnreviews.com/en/2019/physical-activity-and-underlying-muscle-biology-in-chronic-obstructive-pulmonary-disease-copd/) - [Usefulness of Biological Clustering Patterns in Chronic Obstructive Pulmonary Disease](https://brnreviews.com/en/2019/usefulness-of-biological-clustering-patterns-in-chronic-obstructive-pulmonary-disease/) - [Telomere-Related Gene Mutations and Lung Diseases: Pulmonary Fibrosis, Emphysema and Lung Cancer](https://brnreviews.com/en/2019/telomere-related-gene-mutations-and-lung-diseases-pulmonary-fibrosis-emphysema-and-lung-cancer/) ## Pages - [TOC Alert - Confirmación / Confirmation](https://brnreviews.com/es/toc-alert-conf/): Gracias, la suscripción ha sido activada con éxito.Thank you, the subscription has been successfully activated. - [Data Protection Policy](https://brnreviews.com/en/data-protection-policy/): This is the data protection policy of PUBLICIDAD PERMANYER SL. It refers to the data it processes in the exercise of its editorial activities in compliance with the General Data Protection Regulation (Regulation (EU) 2016/679 of the European Parliament and the Council, of 27 April 2016).Who is the data controller?The data controller is PUBLICIDAD PERMANYER SL (hereinafter PUBLICIDAD PERMANYER), with VAT No B08327512, domiciled at calle Mallorca, 310, 08037 Barcelona, telephone 93 207 5920, e-mail permanyer@permanyer.com, www.permanyer.com. Entity registered in the Companies Registry Office of Barcelona, volume 8.730, folio 219, page 72.874.Who is the Data Protection Officer?The Data Protection Officer […] - [Política de protección de datos](https://brnreviews.com/es/politica-de-proteccion-de-datos/): Esta es la política de protección de datos de PUBLICIDAD PERMANYER SL. Hace referencia a los datos que trata en el ejercicio de sus actividades editoriales dando cumplimiento al Reglamento General de Protección de Datos (Reglamento (UE) 2016/679 del Parlamento Europeo y del Consejo, de 27 de abril de 2016).¿Quién es el responsable del tratamiento de los datos personales?El responsable del tratamiento de los datos personales es PUBLICIDAD PERMANYER SL (en adelante PUBLICIDAD PERMANYER), con CIF B08327512, domicilio en calle Mallorca, 310, 08037 Barcelona, teléfono 93 207 5920, correo electrónico permanyer@permanyer.com, www.permanyer.com. Figura inscrita en el Registro Mercantil de Barcelona, […] - [Permissions & Reprints](https://brnreviews.com/en/permissions-reprints/): Reusing content1.- To request a quote for reprinting or translatingThe language in which the article is to be printed.Option: Personalization of your reprints by adding your company logo or advertisement (key positions to be defined).For a personalized offer, please contact permanyer@permanyer.com including the following information:Details of the journal, title, publication year, issue and page numbers.The language in which the article is to be printed.Number of copies.Full contact details, including an e-mail address and phone number.2.- To request permission for other reuse contentPlease provide citation details.The language in which the reuse content is to be printed.For a personalized offer, please contact […] - [Permisos y reimpresiones](https://brnreviews.com/es/permisos-y-reimpresiones/): Utilización de Contenidos1.- Solicitud de reprints o traducciones:En el mismo idioma de la publicación o traducido a cualquier idioma.Opción de personalizar el reprint con el logo de su Compañía o publicidad (espacios a determinar).Para recibir presupuesto contactar a permanyer@permanyer.com incluyendo la siguiente información:Referencia bibliográfica completa (publicación, autor, título, volumen, páginas).Idioma en el que desea los reprints.Número de ejemplares.Contacto: empresa, persona de contacto, correo electrónico, teléfono.2.- Solicitud de AutorizacionesPara reproducir partes de un artículo (tablas, figuras, etc.).En el mismo idioma o traducido a cualquier idioma.Para recibir autorización y/o presupuesto contactar a permanyer@permanyer.com incluyendo:Información completa del material que desea utilizar (artículo completo, […] - [Legal notice and data protection policy](https://brnreviews.com/en/legal-notice/): Legal Notice and data protection policyBRN Reviews is a publication by Permanyer España, S.A. de C.V., and registered address at Mallorca, 310, 08037 Barcelona, Spain. This website and the www.brnreviews.com domain are managed by Permanyer España, S.A. de C.V. Access to and use of BRN Reviews’ website implies acceptance of the following conditions.Intellectual and industrial propertyThe contents that are presented by means of this website, such as (indicative listing) the composition, the design, the texts, the images, the graphics, the headers, the logotypes and other distinctive signs, are the exclusive property of Permanyer España, S.A. de C.V. or of third […] - [Aviso legal](https://brnreviews.com/es/aviso-legal/): Revista Dolor es una publicación editada por Publicidad Permanyer, Este sitio web y el dominio http://dolor.es son gestionados por Publicidad Permanyer, S.L.U., sociedad inscrita en el Registro Mercantil de Barcelona, Tomo 8.730, Folio 219, Hoja 72.874, Inscripción 6ª, con CIF B08327512, domicilio social en Calle Mallorca, núm. 310, Barcelona (CP 08037), tel. 93 207 59 20 – Fax 93 457 66 42 y e-mail permanyer@permanyer.com.El acceso y uso del sitio web de Revista Dolor comporta la aceptación de las siguientes condiciones.Propiedad intelectual e industrialLos contenidos que se presenten por medio de este sitio web, como son (enumeración indicativa) la composición, […] - [Ejemplo EN](https://brnreviews.com/en/ejemplo-en/): This is a test - [Ejemplo ES](https://brnreviews.com/es/ejemplo/): Esto es un ejemplo - [Toc Alert](https://brnreviews.com/en/toc-alert-2/): TOC ALERT allows you to be automatically notified when a new issue of the journal is published. - [Authors](https://brnreviews.com/en/authors/) - [Ahead of print](https://brnreviews.com/en/ahead-of-print/) - [Editorial & Peer review](https://brnreviews.com/en/editorial-peer-review/): evaluates manuscripts through a double-blinded peer-review, meaning that both reviewers and authors are anonymous throughout the process. Internal procedures guarantee that this standard is applied to all articles authored by members of the editorial team.The editorial process comprises 7 steps:1. Review by the editorial officeUpon reception of the manuscript, the editorial office reviews the document to ensure adhesion to author guidelines (format, style, sections, references, etc.), which are available at the journal website.2. Review by the Editor in Chiefa. The editor in chief reviews the manuscript, and validates if the theme, originality and scientific quality of the paper are fit […] - [Procedure for complaints and/or appeals](https://brnreviews.com/en/procedure-for-complaints-and-or-appeals/): This procedure is related to complaints about policy, procedure or actions from the editorial staff of the journal. The journal’s editorial staff is open to comments and complaints that contribute to the improvement of our processes. We are committed to answer such complaints in an expedite and constructive manner.The procedure to file a complaint is as follows:The individual that files a complaint must do so via the following email address: permanyer@permanyer.com. A complaint must be related to an error in the editorial procedure, such as a disproportionately long delay in replying to an author or reaching a decision regarding a manuscript, […] - [Sponsors](https://brnreviews.com/en/sponsors/): Printed issues may have commercial advertisements. However, sponsors do not participate in the selection or edition of the published content. The editorial board is independent from the commercial sponsorship. - [Journal Information](https://brnreviews.com/en/journal-information/): ISSN: e-ISSN: BRN Reviews, the official publication of the Barcelona Respiratory Network, is a peer-reviewed, quarterly, open-access journal dedicated to clinical and scientific excellence. Our mission is to publish high-impact reviews that synthesize the latest advances and trends in respiratory medicine.The journal publishes comprehensive reviews covering the entire spectrum of respiratory health, with a strategic focus on translational medicine (genomics, proteomics, molecular biology) and its clinical applications (new biomarkers, or therapeutic targets); clinical innovation (reviews on state-of-the-art diagnostic tools, advanced imaging, and novel pharmacological or non-pharmacological interventions in pulmonary diseases); precision medicine (endotypes, phenotypes, and personalized approaches to respiratory care), […] - [Funding](https://brnreviews.com/en/funding/): is the official scientific publication of Barcelona Respiratory Network, it being the journal’s main funding source.The journal firmly supports the open access initiative and does not charge authors for the review, processing, evaluation and publication of articles, and all published works are under the terms of the Creative Commons Attribution License (CC BY-NC-ND 4.0). - [Ethical policies](https://brnreviews.com/en/ethical-policies/): The journal follows the best practice guidelines described by the Committee on Publication Ethics (COPE). Here we detail briefly all points. For more information, visit please the official website on Core practices from COPE.Protection of people and animalsAll studies that involve data, procedures, treatments, etc. in humans must have written authorization from an ethics committee of the participating institution, which must be attached to the manuscripts submitted on the platform, in addition to following the ethical guidelines of the World Medical Association and the Declaration of Helsinki. available at:  http://www.wma.net. Authors must state in the section «Methods» that the procedures used in patients […] - [Contact](https://brnreviews.com/en/contact/): If you need more information about the journal, please contact us:PermanyerMallorca, 31008037 Barcelona (Spain)permanyer@permanyer.comEditor-in-ChiefDr. Xavier Muñoz Gallxavier.munoz@vallhebron.cat - [Open access & Licensing](https://brnreviews.com/en/open-access-licensing/): strongly supports the open access initiative (no fee to publish or to read) and uses the Creative Commons Attribution License (CC BY-NC-ND 4.0). This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher, Society or the author, provided that the purpose is non commercial, the content is not modified and the original work is […] - [Editorial Polices](https://brnreviews.com/en/editorial-polices/): Editorial Policies is governed according to the following policies:The journal will have a unique name and design, it will have publication licenses (including Creative Commons), national and international indexing and ISSN. It will have a secure website.Scientific manuscripts on medicine, of national and international origin and interest, in English, including studies with negative results, that adhere to the international recommendations of good practices will be evaluated.Open accessWorld Health Organization: https://www.who.int/about/policies/publishing/open-accessPlan S: https://www.coalition-s.org/plan_s_principles/International Committee of Medical Journal Editors: https://www.icmje.org/icmje-recommendations.pdfCOPE Core practices: https://publicationethics.org/core-practicesREWARD: https://www.thelancet.com/campaigns/efficiency/statementEQUATOR (Enhancing the QUAlity and Transparency Of health Research): https://www.equator-network.org/about-us/ Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 Update. The […] - [Operations Manual](https://brnreviews.com/en/operations-manual/): Objective. The purpose of this operating manual is to regulate the organization and operation of Barcelona Respiratory Network Reviews journal.Definitions. The following abbreviations are included in this Operations Manual:BRN Reviews: Barcelona Respiratory NetworkPublisher: Publicaciones PermanyerJournal: Barcelona Respiratory Network Reviews General Terms:These provisions shall be mandatory for everybody involved in the functioning of the Journal, authors, and peer reviewers alike.BRN is the proprietor of the Journal, of the rights of the registered trademark, and the corresponding copyrights.During the agreement between BRN and the Publisher, the latter holds all rights regarding the publication of the Journal.Both the trademark and copyrights owned by the […] - [Authors Instructions](https://brnreviews.com/en/authors-instructions/): INSTRUCTIONS FOR SUBMISSION OF MANUSCRIPTS Authors are asked to send their mansucripts in electronic format and using British spelling in compliance with those formulated by the International Committee of Medical Journal Editors (www.icmje.org). Barcelona Respiratory Network (BRN) Reviews publishes review articles reporting scientific studies, clinical research and innovation which contribute to overall knowledge of respiratory health by invitation.Manuscripts submitted to BRN Reviews will be accepted with the understanding that the authors have not submitted their material to another journal or published the material elsewhere. Authors are asked to disclose any affiliations, including financial, consultancy, or institutional associations that might lead to bias or conflict […] - [Editorial Board](https://brnreviews.com/en/editorial-board/): Editor-in-ChiefMuñoz Gall, Xavier (MD), (PhD).  Servei de Pneumologia, Hospital Universitari Vall d’Hebron, Barcelona, SpainEditorial and Production DirectorAhn Rios, María S. (PhD). Publicaciones Permanyer. Barcelona, SpainAssociate EditorsGarcía-Aymerich, Judith (MD). Institute for Global Health (ISGlobal). Barcelona, SpainSellarés, Jacobo (MD). Hospital Clínic-IDIBAPS, Unisitat de Barcelona, SapainBlanco, Isabel (MD). Hospital Clínic-IDIBAPS, Universitat de Barcelona, SpainSibila, Oriol (MD). Hospital Sant Pau, Universitat Autònoma de Barcelona. Barcelona, SpainAdvisory Editorial BoardAntó, Josep Mª (MD). Institute for Global Health (ISGlobal), Barcelona, SpainAnzueto, Antonio (MD). University of Texas Health Science Center, San Antonio, TX, USBarbé, Ferran (MD). Hospital Arnau de Vilanova, Universitat de Lleida, Lleida, SpainBarberà, Joan Albert (MD). Hospital Clínic-IDIBAPS, Universitat […] - [Code of conduct for reviewers](https://brnreviews.com/en/code-of-conduct-for-reviewers/): Reviewers of manuscripts submitted to   are committed to adhering to and acting in accordance with the principles of responsibility, integrity, confidentiality, impartiality, and objectivity, and shall perform their review duties with absolute transparency.Any potential conflicts of interest must be disclosed.Editors and reviewers must be aware that the use of generative artificial intelligence in manuscript review may constitute a breach of confidentiality terms. For more information: ICMJE: Use of artificial intelligence in the review processReviewers must request authorization from the Editor-in-Chief if they wish to use artificial intelligence tools to review manuscripts.Reviewers for  are committed to upholding the principles of confidentiality, […] - [Code of conduct for authors](https://brnreviews.com/en/code-of-conduct-for-authors/): Authors submitting manuscripts to   are expected to adhere to the principles of honesty, integrity, responsibility, and transparency.In any case, they must declare any potential conflicts of interest and/or financing, scholarship, or payment of fees from the private sector, received in the last 3 years, or during the development of their research.The following actions will be considered bad practices and may lead to the retraction of the manuscript:PlagiarismLack of adherence to international ethical standards in the development of research.Data fractioning or salami slicingFalsification, appropriation, or unauthorized reproduction of data, figures, images, algorithms, or tables.Duplicate or redundant publicationManipulation of bibliographic citations, including […] - [Autores](https://brnreviews.com/es/autores/) - [Publicación adelantada](https://brnreviews.com/es/publicacion-adelantada/) - [Comité editorial](https://brnreviews.com/es/comite-editorial/): DIRECTORC. de Barutell FarinósDIRECTORC. de Barutell FarinósEDITORES ASOCIADOSD. Abejón(Madrid)J.L. Aguilar(Palma de Mallorca)J.E. Baños(Barcelona)C. Belmonte(Alicante)R. Belvís(Barcelona)C. Busquets(Barcelona)L. Cánovas(Ourense)J. Carceller(Santander)A.M. Casas(Barcelona)E. Català(Barcelona)F. Cerveró(Montreal, Canadá)J. de Andrés(Valencia)F. Domingo(Barcelona)M. Farré(Barcelona)P. Fenollosa(Valencia)M.L. Franco(Bilbao)R. Gálvez(Granada)E. García Quetglas(Pamplona)J. Insausti(Madrid)M. López(Ferrol)M. Lorente(Barcelona)R. Maldonado(Barcelona)J. Marco(Barcelona)M. Marín(San Sebastian)F. Miralles(Alicante)J. Molet(Barcelona)A. Montero(Lleida)C. Muriel(Salamanca)C. Pérez(Madrid)J. Pérez Cajaraville(Pamplona)C. Pichot(Barcelona)M.ªV. Ribera(Barcelona)F. Reinoso-Barbero(Madrid)F. Robaina(Las Palmas)D. Rodrigo Royo(Zaragoza)J.L. Rodríguez(Sta. Cruz de Tenerife)R. Ruiz(Barcelona)M. Rull(Tarragona)D. Samper(Barcelona)S. Suso(Barcelona) - [TOC Alert](https://brnreviews.com/es/toc-alert/): TOC ALERT le permitirá ser notificado automáticamente cuando un nuevo número de la revista sea publicado. - [Home - EN](https://brnreviews.com/en/): To see articles from 2018 to 2022 click here. To see articles from 2011 to 2017 click here. To see articles from 2005 to 2011 click here. Comportamiento histórico H-INDEX: 6 CiteScore Tiempos Editoriales Tasa de rechazo (Ene-Jun): 24.66% Google Scholar: H5:8 - [Contacto](https://brnreviews.com/es/contacto/): Si usted requiere información acerca de la revista, por favor, contáctenosPermanyerMallorca, 31008037 Barcelona (España)Arquímedes 190Colonia PolancoDelegación Miguel Hidalgo11560, Ciudad de México (México)permanyer@permanyer.com - [Patrocinadores](https://brnreviews.com/es/patrocinadores/): Algunos números de la revista impresa pueden tener anuncios de patrocinadores. Sin embargo, los patrocinadores no participan de ninguna forma en la selección o edición del contenido publicado.El comité editorial de la revista es independiente de los patrocinadores comerciales. - [Acceso abierto y Licencia](https://brnreviews.com/es/acceso-abierto-y-licencia/):  apoya firmemente la iniciativa de acceso abierto (sin pago para publicar ni leer) y usa la licencia de uso abierto Creative Commons Attribution License (CC BY-NC-ND 4.0). Es una revista de acceso abierto, que quiere decir que todo el contenido está disponible de forma gratuita a todos los usuarios y sus instituciones. Cualquier usuario puede leer, descarga, copiar, distribuir, imprimir, buscar, ligar al texto completo de cualquiera de los artículos o cualquier otro uso lícito, sin necesidad de pedir permiso al autor, a la Sociedad o editorial, siempre que sea para uso no comercial, no modifique la obra y el trabajo […] - [Procedimiento para quejas y apelaciones](https://brnreviews.com/es/procedimiento-para-quejas-y-apelaciones/): Este procedimiento se aplica a las quejas sobre las políticas, procedimientos o acciones del personal editorial de la revista. El personal editorial de la revista esta abierto a recibir todas las quejas que les permitan ser más justos y mejorar los procesos, y comprometidos en responder de forma rápida y constructivamente. El procedimiento para realizar una queja se describe a continuación:Todas las quejas deberán enviarse a la siguiente dirección: permanyer@permanyer.com. Las quejas deben estar relacionadas con un error en el procedimiento editorial, como por ejemplo una gran demora, una respuesta grosera o un grave error de juicio.La queja debe ser sobre algo […] - [Fuentes de ingreso](https://brnreviews.com/es/fuentes-de-ingreso/): es el órgano oficial de difusión científica de la , siendo esta la fuente principal de financiamiento de la revista. apoya firmemente la iniciativa de acceso abierto, no realiza cargos económicos por la revisión, procesamiento, evaluación y publicación de los artículos, así mismo, todas las obras publicadas están bajo los términos de la licencia Creative Commons Attribution License. - [Ética editorial](https://brnreviews.com/es/etica-editorial/): La revista sigue el código de buenas prácticas descrito por el Committee on Publication Ethics (COPE). A continuación, se detallan brevemente todos los puntos. Para más información por favor, visite la página oficial en Core practices en COPE.Protección de personas y animalesTodos los estudios que involucren datos, maniobras, tratamientos, etc., en humanos, deberán de contar con la autorización por escrito de un comité de ética de la institución participante, el cual debe ser anexado a los papeles sometidos en la plataforma, además de seguir las norma éticas de la Asociación Médica Mundial y la Declaración de Helsinki disponible en: http://www.wma.net. Los autores deben mencionar en […] - [Proceso de revisión](https://brnreviews.com/es/proceso-de-revision/):  evalúa los manuscritos a través de una revisión por pares doble ciego, lo que significa que tanto los revisores como los autores son anónimos durante todo el proceso. Los procedimientos internos garantizan que este estándar se aplique a todos los artículos escritos por miembros del equipo editorial.El proceso editorial se realiza a través del gestor de manuscritos online en: https://publisher.revistaamaof.permanyer.com, y consta de 7 pasos:1. Revisión por parte de la oficina editorial:Una vez que se somete el artículo, la oficina editorial revisa el documento para que cumpla las guías para los autores (formato y estilo del documento, secciones, bibliografía, etc.) disponibles en […] - [Código de conducta para autores](https://brnreviews.com/es/codigo-de-conducta-para-autores/): Los autores de manuscritos enviados a la revista  se comprometen a seguir los principios de honestidad, integridad, responsabilidad y transparencia.En cualquier caso, deberán declarar cualquier potencial conflicto de intereses y/o financiamiento, beca o pago de honorarios por la iniciativa privada recibidos en los últimos 3 años, o durante el desarrollo de su investigación.Las siguientes acciones se considerarán malas prácticas y podrán conllevar a la retracción del manuscrito:PlagioFalta de apego los estándares éticos internacionales en el desarrollo de la investigaciónFraccionamiento de datos o salami slicingFalsificación, apropiación, o reproducción no autorizada por parte del autor intelectual de datos, figuras, imágenes, algoritmos, o […] - [Código de conducta para revisores](https://brnreviews.com/es/codigo-de-conducta-para-revisores/): Los revisores de los manuscritos sometidos a la revista   se comprometen a observar y a actuar siguiendo los principios de responsabilidad, integridad, confidencialidad, imparcialidad, y objetividad, y desempeñarán su labor de revisor con absoluta transparencia.En todo caso se deberá declarar posibles conflictos de interés.Los editores y revisores deben tener en cuenta que la utilización de inteligencia artificial generativa para la revisión de manuscritos puede suponer una violación a los términos de confidencialidad. Para más información: ICMJE: Use of artificial intelligence in the review processLos revisores deberán solicitar autorización del Editor Jefe si desean emplear herramientas de inteligencia artificial para revisar […] - [Instrucciones para autores](https://brnreviews.com/es/instrucciones-para-autores/): La revista  está abierta a publicar trabajos sin invitación previa si se adecúan y son contemporáneos con la línea editorial de la revista.La revista considerará contribuciones en las siguientes secciones:• Artículos Originales• Artículos de Revisión• Casos Clínicos• Cartas al EditorFormato del manuscritoEl texto deberá estar escrito a doble espacio en fuente tipográfica Times New Roman a 12 puntos y debe comenzar en página nueva cada una de las siguientes secciones:Página frontal• Título, nombre y apellido(s) de cada autor (sin títulos o cargos)• Los departamentos institucionales en los que están adscritos• Nombre y correo electrónico del autor de correspondenciaManuscrito• Resumen* y […] - [Políticas editoriales](https://brnreviews.com/es/politicas-editoriales/):  se rige de acuerdo con las siguientes políticas:Tendrá un nombre y diseño único, contará con licencias de publicación (incluida Creative Commons), indización nacional e internacional e ISSN. Contará con un sitio electrónico seguro. Se evaluarán manuscritos científicos en el área de la medicina, de procedencia nacional e internacional, en español o inglés y estudios con resultados negativos, que se apeguen a las recomendaciones internacionales de buenas prácticas.Acceso abiertoWorld Health Organization: https://www.who.int/about/policies/publishing/open-accessPlan S: https://www.coalition-s.org/plan_s_principles/International Committee of Medical Journal Editors: https://www.icmje.org/icmje-recommendations.pdfCOPE Core practices: https://publicationethics.org/REWARD: https://www.thelancet.com/campaigns/efficiency/statementEQUATOR (Enhancing the QUAlity and Transparency Of health Research): https://www.equator-network.org/about-us/Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 […] - [Manual de operaciones](https://brnreviews.com/es/manual-de-operaciones/): Revista Mexicana de Comunicación, Audiología, Otoneurología y Foniatría (RMCAOF) Objetivo. El presente manual de operación tiene como objeto regular la organización y operación de la RMCAOF.   Definiciones. Para los efectos del presente manual de operaciones, se entenderá por:AMCAOF: Asociación Mexicana de Comunicación, Audiología, Otoneurología y Foniatría, A.C.Editorial: Publicaciones Permanyer Revista: Revista Mexicana de Comunicación, Audiología, Otoneurología y FoniatríaTérminos generalesLos siguientes criterios son de seguimiento obligatorio para toda persona involucrada en el funcionamiento de la Revista, autores y revisores pares. AMCAOF es propietaria de la Revista, de los derechos de la marca comercial y de los derechos de autor correspondientes.Durante la vigencia del convenio suscrito entre AMCAOF y la […] - [Información de la revista](https://brnreviews.com/es/informacion-de-la-revista/): ISSN: 0214-0659e-ISSN: 1698-7632Dolor® Investigación, Clínica & Terapéutica es la primera revista médica en español sobre este área del conocimiento. Publicaciones Permanyer edita trimestralmente la revista desde 1985. En ella colaboran los mejores especialistas que aportan los últimos avances en la clínica y terapéutica del dolor. La revista Dolor®Investigación, Clínica & Terapéutica está incluida en EMBASE / Excerpta Medica. - [Número actual](https://brnreviews.com/es/numero-actual/): Número actual - [Home](https://brnreviews.com/es/): Para ver artículos de 2018 a 2022 haga click aquí Para ver artículos de 2011 a 2017 haga click aquí Para ver artículos de 2005 a 2011 haga click aquí Comportamiento histórico H-INDEX: 6 CiteScore Tiempos Editoriales Tasa de rechazo (Ene-Jun): 24.66% Google Scholar: H5:8 [comment]: # (Generated by Hostinger Tools Plugin)